Intrahepatic expression of the co-stimulatory molecules programmed death-1, and its ligands in autoimmune liver disease

Pathology International

Volumn 57, Issue 8, 2007, Pages 485-492

  Oikawa, Tsunekazu ^a,b   Takahashi, Hiroki ^a   Ishikawa, Tomohisa ^a   Hokari, Atsushi ^a   Otsuki, Noriko ^b   Azuma, Miyuki ^b   Zeniya, Mikio ^a   Tajiri, Hisao ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Autoimmune hepatitis; B7 DC; B7 H1; Primary biliary cirrhosis; Programmed death 1

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTINUCLEAR ANTIBODY; APOPTOSIS REGULATORY PROTEIN; MITOCHONDRION ANTIBODY; PREDNISOLONE; PROGRAMMED DEATH 1 PROTEIN; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID;

ADULT; ARTICLE; AUTOIMMUNE HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; KUPFFER CELL; LIVER; LIVER BIOPSY; LIVER SINUSOID; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; MALE; PORTAL VEIN; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; UPREGULATION;

ADULT; ANTIGENS, CD; ANTIGENS, CD80; APOPTOSIS REGULATORY PROTEINS; BIOLOGICAL MARKERS; BIOPSY; ENDOTHELIUM, VASCULAR; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOENZYME TECHNIQUES; KUPFFER CELLS; LIGANDS; LIVER; LIVER CIRRHOSIS, BILIARY; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; T-LYMPHOCYTES; UP-REGULATION;

EID: 34447092921     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2007.02129.x     Document Type: Article

References (44)

1. Ichiki Y, Aoki CA, Bowlus CL, Shimoda S, Ishibashi H, Gershwin ME. T cell immunity in autoimmune hepatitis. Autoimmun Rev 2005 4 : 315 21.
2. Krawitt EL. Autoimmune hepatitis. N Engl J Med 1996 334 : 897 903.
3. Kaplan MM. Primary biliary cirrhosis. N Engl J Med 1996 335 : 1570 80.
4. Coppel RL, Gershwin ME. Primary biliary cirrhosis: The molecule and the mimic. Immunol Rev 1995 144 : 17 49.
5. Ishibashi H, Nakamura M, Shimoda S, Gershwin ME. T cell immunity and primary biliary cirrhosis. Autoimmun Rev 2003 2 : 19 24.
6. Greenfield EA, Nguyen KA, Kuchroo VK. CD28/B7 costimulation: A review. Crit Rev Immunol 1998 18 : 389 418.
7. Carreno BM, Collins M. The B7 family of ligands and its receptors: New pathways for costimulation and inhibition of immune responses. Annu Rev Immunol 2002 20 : 29 53.
8. Nishimura H, Honjo T. PD-1: An inhibitory immunoreceptor involved in peripheral tolerance. Trends Immunol 2001 22 : 265 8.
9. Agata Y, Kawasaki A, Nishimura H et al. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int Immunol 1996 8 : 765 72.
10. Ishida Y, Agata Y, Shibahara K, Honjo T. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J 1992 11 : 3887 95.
11. Latchman Y, Wood CR, Chernova T et al. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol 2001 2 : 261 8.
12. Freeman GJ, Long AJ, Iwai Y et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 2000 192 : 1027 34.
13. Dong H, Zhu G, Tamada K, Chen L. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med 1999 5 : 1365 9.
14. Iwai Y, Terawaki S, Ikegawa M, Okazaki T, Honjo T. PD-1 inhibits antiviral immunity at the effector phase in the liver. J Exp Med 2003 198 : 39 50.
15. Iwai Y, Ishida M, Tanaka Y, Okazaki T, Honjo T, Minato N. Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade. Proc Natl Acad Sci USA 2002 99 : 12 93 7.
16. Dong H, Strome SE, Salomao DR et al. Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion. Nat Med 2002 8 : 793 800.
17. Yamazaki T, Akiba H, Iwai H et al. Expression of programmed death 1 ligands by murine T cells and APC. J Immunol 2002 169 : 5538 45.
18. Nishimura H, Nose M, Hiai H, Minato N, Honjo T. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 1999 11 : 141 51.
19. Salama AD, Chitnis T, Imitola J et al. Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis. J Exp Med 2003 198 : 71 8.
20. Ansari MJ, Salama AD, Chitnis T et al. The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J Exp Med 2003 198 : 63 9.
21. Tsushima F, Iwai H, Otsuki N et al. Preferential contribution of B7-H1 to programmed death-1-mediated regulation of hapten-specific allergic inflammatory responses. Eur J Immunol 2003 33 : 2773 82.
22. Dong H, Strome SE, Matteson EL et al. Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis. J Clin Invest 2003 111 : 363 70.
23. Kobayashi M, Kawano S, Hatachi S et al. Enhanced expression of programmed death-1 (PD-1)/PD-L1 in salivary glands of patients with Sjogren's syndrome. J Rheumatol 2005 32 : 2156 63.
24. Youngnak-Piboonratanakit P, Tsushima F, Otsuki N et al. The expression of B7-H1 on keratinocytes in chronic inflammatory mucocutaneous disease and its regulatory role. Immunol Lett 2004 94 : 215 22.
25. Kanai T, Totsuka T, Uraushihara K et al. Blockade of B7-H1 suppresses the development of chronic intestinal inflammation. J Immunol 2003 171 : 4156 63.
26. Toda G, Zeniya M, Watanabe F et al. Present status of autoimmune hepatitis in Japan: Correlating the characteristics with international criteria in an area with a high rate of HCV infection. Japanese National Study Group of Autoimmune Hepatitis. J Hepatol 1997 26 : 1207 12.
27. Scheuer P. Primary biliary cirrhosis. Proc R Soc Med 1967 60 : 1257 60.
28. Youngnak P, Kozono Y, Kozono H et al. Differential binding properties of B7-H1 and B7-DC to programmed death-1. Biochem Biophys Res Commun 2003 307 : 672 7.
29. Nuriya S, Yagita H, Okumura K, Azuma M. The differential role of CD86 and CD80 co-stimulatory molecules in the induction and the effector phases of contact hypersensitivity. Int Immunol 1996 8 : 917 26.
30. Palmer JM, Kirby JA, Jones DE. The immunology of primary biliary cirrhosis: The end of the beginning? Clin Exp Immunol 2002 129 : 191 7.
31. Leifeld L, Trautwein C, Dumoulin FL, Manns MP, Sauerbruch T, Spengler U. Enhanced expression of CD80 (B7-1), CD86 (B7-2), and CD40 and their ligands CD28 and CD154 in fulminant hepatic failure. Am J Pathol 1999 154 : 1711 20.
32. Fiore G, Piazzolla G, Galetta V, Caccetta L, Schiraldi O, Antonaci S. Liver tissue expression of CD80 and CD95 antigens in chronic hepatitis C: Relationship with biological and histological disease activities. Microbios 1999 97 : 29 38.
33. Tsuneyama K, Harada K, Yasoshima M, Kaji K, Gershwin ME, Nakanuma Y. Expression of co-stimulatory factor B7-2 on the intrahepatic bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis: An immunohistochemical study. J Pathol 1998 186 : 126 30.
34. Kaji K, Tsuneyama K, Nakanuma Y et al. B7-2 positive cells around interlobular bile ducts in primary biliary cirrhosis and chronic hepatitis C. J Gastroenterol Hepatol 1997 12 : 507 12.
35. Zachou K, Rigopoulou EI, Tsikrikoni A et al. Autoimmune hepatitis type 1 and primary biliary cirrhosis have distinct bone marrow cytokine production. J Autoimmun 2005 25 : 283 8.
36. Nagano T, Yamamoto K, Matsumoto S et al. Cytokine profile in the liver of primary biliary cirrhosis. J Clin Immunol 1999 19 : 422 7.
37. Harada K, Van de Water J, Leung PS et al. In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: Predominance of the Th1 subset. Hepatology 1997 25 : 791 6.
38. Kamihira T, Shimoda S, Nakamura M et al. Biliary epithelial cells regulate autoreactive T cells: Implications for biliary-specific diseases. Hepatology 2005 41 : 151 9.
39. Dong H, Zhu G, Tamada K, Flies DB, van Deursen JM, Chen L. B7-H1 determines accumulation and deletion of intrahepatic CD8(+) T lymphocytes. Immunity 2004 20 : 327 36.
40. Lohse AW, zum Buschenfelde KH, Franz B, Kanzler S, Gerken G, Dienes HP. Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: Evidence for it being a hepatic form of PBC in genetically susceptible individuals. Hepatology 1999 29 : 1078 84.
41. Chazouilleres O, Wendum D, Serfaty L, Montembault S, Rosmorduc O, Poupon R. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: Clinical features and response to therapy. Hepatology 1998 28 : 296 301.
42. Bowen DG, McCaughan GW, Bertolino P. Intrahepatic immunity: A tale of two sites? Trends Immunol 2005 26 : 512 17.
43. Crispe IN. Hepatic T cells and liver tolerance. Nat Rev Immunol 2003 3 : 51 62.
44. Calne RY, Sells RA, Pena JR et al. Induction of immunological tolerance by porcine liver allografts. Nature 1969 223 : 472 6.